Jeffrey Szymanski

Assistant Professor

Mayo Clinic Minnesota

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jeffrey Szymanski is an Assistant Professor at Mayo Clinic in Rochester, Minnesota, USA. His research focuses on the application of cell-free DNA biomarkers for early cancer detection, including malignant and premalignant tumors. Recent publications explore genomic patterns in tumor evolution, minimal residual disease detection, and the effects of treatments such as doxorubicin on cancer outcomes.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Brendan C. Dickson

CANADA

View details

Dengfeng Cao

Washington University School of Medicine

UNITED STATES

View details

Robert Hayashi

Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Amy Armstrong

Assistant Professor

Washington University Physicians

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeffrey Szymanski

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

LINE-1 Retrotransposons as Cell-free DNA Biomarkers for Multicancer Early Detection

Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics

Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer

Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity

Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA

LITE SABR M1: A phase I trial of Lattice stereotactic body radiotherapy for large tumors

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study

Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis

Erratum: Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study (PLoS Med (2021) 18:8 (e1003732) DOI: 10.1371/journal.pmed.1003732)

Collaborators (4)

Brendan C. Dickson

Dengfeng Cao

Robert Hayashi

Amy Armstrong

Make your next move.